SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: J.B. Piper who wrote (245)1/21/1997 9:14:00 PM
From: surfinSteve   of 1172
 
EARNINGS ARE OUT!!! $866K in revenues!

Here's the link:

pcquote.newsalert.com

Here's some of the details:

SUNNYVALE, Calif., Jan. 21 /PRNewswire/ -- ChemTrak, Inc. (Nasdaq: CMTR),
a leading personal diagnostics company, today reported a net loss of
$1,454,000 ($0.13 loss per share), for the three month period ended December
31, 1996. Revenues were $866,000 for the period, including $443,000 in
product sales. During the similar period in 1995, the quarter's operations
resulted in net income of $1,454,000 or $0.15 per share, with revenues of
$3,836,000, including $236,000 in product sales.

CHEMTRAK INCORPORATED
SUMMARY STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(Unaudited)

Fourth quarter ended Year Ended
December 31 December 31

1996 1995 l996 l995

Net revenues:
Product sales $443 $236 $2,463 $2,171
Funded research and other 423 3600 598 4,725
Total revenues 866 3,836 3,061 6,896

Cost and expenses:
Cost of product revenues 726 636 3,201 3,191
Research and development 519 736 2,439 2,793
Marketing, general and
administrative 1,094 1,049 4,431 2,941
Purchase of in-process
research and development --- --- --- 1,500
Total costs and expenses2,339 2,421 10,071 10,425

Operating Income (loss) (1,473) 1,415 (7,010) (3,529)

Interest and other
income net 9 39 59 260
Net income (loss) $(1,454) $ 1,454 (6,951) (3,269)
Net income (loss)
per share ($O.l3) $0.15 (0.68) (0.34)

Sales used in calculating
per share data 11,114 9,724 10,230 9,649

CHEMTRAK INCORPORATED
BALANCE SHEET DATA
(In thousands)

Dec. 31, 1996 Dec. 31, 1995
Cash, cash equivalents and
short-term investments $4,692 $6,254
Working capital 4,899 5,944
Property and equipment, net 2,738 3,248
Total assets 9,084 10,383
Total stockholders' equity 5,490 9,018

SOURCE ChemTrak, Inc.
CONTACT: Alene A. Holzman, Vice President of ChemTrak, Inc.,
408-773-8156; or Dan McCue of Freeman McCue, 714-557-3663
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext